Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Isomorphic Labs sets up US presence in Cambridge, with an eye on clinical trials By Katie Palmer STAT,Updated June 17, 2025, 10:57 a.m.

Isomorphic Labs sets up U.S. presence, with an eye on clinical trials The Alphabet company, spun off from DeepMind, is hiring a new chief medical officer and adding an office in Cambridge ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...

LONDON and BOSTON, June 17, 2025 /PRNewswire/ -- Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr.

China has launched a controversial new civilian flight path near Taiwan, saying the route will reduce air traffic congestion.

What was it like to track the rising danger of this asteroid, and to ultimately determine that it’d miss us? This is the ...

(The Center Square) – The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ genetic data to international labs.